Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Mgus Latest News"

04:24 EDT 23rd April 2014 | BioPortfolio

Original Source: The White House crusade against ... MGUS?

Matching Channels

Monoclonal Gammopathy of Undetermined Significance MGUS

Biotherapeutics - news, views, reports and blogs

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Latest Biotherapeutics News - RSS feed - Twitter account - @Biotherapeutic1 -...

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Devices - medical, biotech, pharma

A medical device is a product which is used for medical purposes in patients, in diagnosis, therapy or surgery.  Medical devices act by physical, mechanical, thermal, physico-chemical or chemic...

Matching News

Precursor of multiple myeloma more common in blacks than whites

Blacks may be twice as likely as whites to develop multiple myeloma because they are more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance (MGUS), a stu...

Precursor of multiple myeloma more common in blacks than whites, study finds (w/ Video)

Blacks may be twice as likely as whites to develop multiple myeloma because they are more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance (MGUS), a May...

Precursor of multiple myeloma more common in blacks than whites, Mayo study finds

(Mayo Clinic) Blacks may be twice as likely as whites to develop multiple myeloma because they are more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance...

Latest M&A news: Teva to acquire Nupathe

Latest M&A news is that Nupathe rejects the acquisiton offer by  Endo Health soultion and has agreed to be acquired by Teva Pharmaceuticals for $144 million in cash. NuPathe Inc.  announced that...

In Watson’s latest healthcare technology news, it takes on personalized brain tumor treatment

Watson is turning into quite the oncology expert. In its latest healthcare technology news, the computer platform is being used as part of a collaboration between IBM and New York...

Topol on Notable Cancer, Drug, and Wearable Technology News

Medscape Editor-in-Chief Eric J. Topol, MD, ushers in the new year with an overview of the latest cancer, pharmacogenomic, and technology news. Medscape

Must Watch News & Earnings: Amgen, Micron Technology, Opko Health, GameStop Corp, Halcon Resources

NEW YORK, November 22, 2013 /PRNewswire/ -- Market Buzz Report, one of the leading online communities for alerting special penny stocks, issues latest news for Amgen, Inc.(NASDAQ:AMGN), Micron Tec...

News digest – kidney cancer rise, EU vote on tobacco control, ‘urine test technology’ and more

This week's cancer news featured our latest figures on kidney cancer, tough new anti-tobacco measures and a fascinating bit of tech to spot bowel cancer.

Matching PubMed Articles

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.

We report a series of 14 patients with myelodysplastic syndrome (MDS) accompanied by a monoclonal gammopathy unrelated to therapy. Twelve of these had monoclonal gammopathy of undermined significance...

Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.

Monoclonal gammopathy of undetermined significance (MGUS), a pre-malignant clone of plasma cells producing a monoclonal paraprotein, is present in ~2% of individuals >50 years. The increased risk of m...

Over one third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal-dominantly inherited risk factor for MGUS/MM.

Since hyperphosphorylated paratarg-7 (pP-7) carrier state was shown to be the first molecularly defined autosomal-dominantly inherited risk factor for monoclonal gammopathy of unknown significance (MG...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement